VOYA Investment Management
ALNY icon

VOYA Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

VOYA Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.1M Sell
148,488
-50,125
-25% -$17.1M 0.05% 285
2025
Q4 		$79M Sell
198,613
-174,743
-47% -$77.3M 0.08% 243
2025
Q3 		$170M Buy
373,356
+162,311
+77% +$66.1M 0.17% 136
2025
Q2 		$68.8M Buy
211,045
+119,901
+132% +$33.2M 0.07% 269
2025
Q1 		$24.6M Sell
91,144
-3,942
-4% -$1.01M 0.03% 469
2024
Q4 		$22.4M Sell
95,086
-13,623
-13% -$3.58M 0.02% 510
2024
Q3 		$29.9M Sell
108,709
-5,525
-5% -$1.44M 0.03% 450
2024
Q2 		$27.8M Buy
114,234
+43,737
+62% +$6.9M 0.03% 444
2024
Q1 		$10.5M Sell
70,497
-13,626
-16% -$2.27M 0.01% 735
2023
Q4 		$16.1M Sell
84,123
-69,981
-45% -$11.9M 0.02% 585
2023
Q3 		$27.3M Buy
154,104
+6,494
+4% +$1.24M 0.03% 436
2023
Q2 		$28M Sell
147,610
-25,030
-14% -$4.96M 0.03% 447
2023
Q1 		$34.6M Sell
172,640
-12,559
-7% -$2.64M 0.04% 410
2022
Q4 		$44M Buy
185,199
+99,505
+116% +$21.2M 0.05% 369
2022
Q3 		$17.2M Buy
85,694
+34,493
+67% +$6.58M 0.02% 540
2022
Q2 		$7.47M Sell
51,201
-7,082
-12% -$1M 0.02% 583
2022
Q1 		$9.52M Sell
58,283
-444
-0.8% -$67.6K 0.02% 638
2021
Q4 		$9.96M Buy
58,727
+21,248
+57% +$3.95M 0.02% 611
2021
Q3 		$7.08M Sell
37,479
-350
-0.9% -$65.7K 0.01% 714
2021
Q2 		$6.41M Sell
37,829
-403
-1% -$59K 0.01% 788
2021
Q1 		$5.4M Sell
38,232
-2,493
-6% -$375K 0.01% 818
2020
Q4 		$5.29M Sell
40,725
-2,095
-5% -$280K 0.01% 799
2020
Q3 		$6.24M Sell
42,820
-1,282
-3% -$182K 0.01% 672
2020
Q2 		$6.53M Buy
44,102
+8,807
+25% +$1.19M 0.02% 661
2020
Q1 		$3.84M Sell
35,295
-682
-2% -$78.7K 0.01% 768
2019
Q4 		$4.14M Sell
35,977
-15,278
-30% -$1.52M 0.01% 863
2019
Q3 		$4.12M Sell
51,255
-1,036
-2% -$82K 0.01% 843
2019
Q2 		$3.79M Buy
52,291
+5,734
+12% +$440K 0.01% 878
2019
Q1 		$4.35M Sell
46,557
-9,665
-17% -$808K 0.01% 829
2018
Q4 		$4.1M Buy
56,222
+6,532
+13% +$502K 0.01% 818
2018
Q3 		$4.35M Sell
49,690
-3,151
-6% -$317K 0.01% 868
2018
Q2 		$5.2M Buy
52,841
+8,513
+19% +$844K 0.01% 806
2018
Q1 		$5.28M Buy
44,328
+13,940
+46% +$1.8M 0.01% 789
2017
Q4 		$3.86M Buy
30,388
+1,011
+3% +$127K 0.01% 883
2017
Q3 		$3.45M Buy
29,377
+1,389
+5% +$119K 0.01% 888
2017
Q2 		$2.23M Sell
27,988
-1,073
-4% -$68.6K 0.01% 1014
2017
Q1 		$1.49M Sell
29,061
-1,426
-5% -$65.9K ﹤0.01% 1143
2016
Q4 		$1.14M Sell
30,487
-1,863
-6% -$78K ﹤0.01% 1261
2016
Q3 		$2.19K Buy
32,350
+934
+3% +$65.9K ﹤0.01% 1017
2016
Q2 		$1.74M Buy
31,416
+1,043
+3% +$65.7K ﹤0.01% 1050
2016
Q1 		$1.91M Sell
30,373
-770
-2% -$51.2K ﹤0.01% 1021
2015
Q4 		$2.93M Sell
31,143
-969
-3% -$89.8K 0.01% 904
2015
Q3 		$2.58M Sell
32,112
-479
-1% -$53.2K 0.01% 941
2015
Q2 		$3.91M Sell
32,591
-642
-2% -$76.7K 0.01% 862
2015
Q1 		$3.47M Buy
33,233
+2,528
+8% +$256K 0.01% 905
2014
Q4 		$2.98M Sell
30,705
-1,789
-6% -$166K 0.01% 959
2014
Q3 		$2.54M Sell
32,494
-235
-0.7% -$15.2K 0.01% 992
2014
Q2 		$2.07M Buy
32,729
+95
+0.3% +$5.65K ﹤0.01% 1094
2014
Q1 		$2.19M Hold
32,634
– – 0.01% 1082
2013
Q4 		$2.1M Buy
32,634
+1,361
+4% +$81.2K ﹤0.01% 1082
2013
Q3 		$2M Hold
31,273
– – 0.01% 1097
2013
Q2 		$970K Buy
+31,273
New +$832K ﹤0.01% 1408

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management's ALNY Position: Q1 2026 in Review

VOYA Investment Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 25% in Q1 2026, selling an estimated $17.1M and leaving 148,488 shares worth $49.1M. The position accounts for 0.05% of the portfolio, ranked #285.

VOYA Investment Management first reported a position in ALNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $170M in Q3 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • VOYA Investment Management held 148,488 shares of Alnylam Pharmaceuticals worth $49.1M as of Q1 2026.
  • VOYA Investment Management sold 50,125 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $17.1M.
  • Alnylam Pharmaceuticals made up 0.05% of VOYA Investment Management's portfolio in Q1 2026, its #285 holding.
  • VOYA Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Alnylam Pharmaceuticals position peaked at $170M in Q3 2025.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.